APA (7th ed.) Citation

ES, A., M, N., H, T., JM, S., & MF, A. (2026). Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis. Clinics in liver disease, 30(2), 391. https://doi.org/10.1016/j.cld.2026.01.004

Chicago Style (17th ed.) Citation

ES, Abreu, Noureddin M, Takahashi H, Schattenberg JM, and Abdelmalek MF. "Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis." Clinics in Liver Disease 30, no. 2 (2026): 391. https://doi.org/10.1016/j.cld.2026.01.004.

MLA (9th ed.) Citation

ES, Abreu, et al. "Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis." Clinics in Liver Disease, vol. 30, no. 2, 2026, p. 391, https://doi.org/10.1016/j.cld.2026.01.004.